United Kingdom

People: Resverlogix Corp (RVX.TO)

RVX.TO on Toronto Stock Exchange

13 Sep 2019
Change (% chg)

$-0.08 (-2.87%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Lu, Shawn 

Mr. Shawn Lu is Director of the company. He is the Chief Financial Officer of HepalinkUSAInc. Mr. Lu has extensive experience in the areas of corporate finance, capital markets and investment financing spanning over 24 years. Prior positions include: Area Manager for BMO Bank ofMontreal; TD Bank Residential Mortgage Manager; TD Bank Senior Financial Advisor; Chief Financial Officer and Vice President of Corporate Finance, Shenzhen Hepalink Biopharmaceutical Co.; Vice President of Investment and Corporate Finance, Shenzhen FuTianXin Investment Co.; General Manager of Corporate Finance Department and Manager of Investment & Finance Department, China Merchant Shekou Port Co. Ltd. Mr. Lu holds the following designations: Canadian Investment Manager (CIM) and a Certified Accountant and Certified Corporate Economist inChina. He has Master of Finance Management and a Master of Corporate Economics and Business Administration.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --